301 related articles for article (PubMed ID: 12189976)
1. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
Porcu M
Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
[No Abstract] [Full Text] [Related]
2. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
3. [Neurohumoral blocking agents].
Kurisu S; Kihara Y
Nihon Rinsho; 2011 Nov; 69 Suppl 9():394-6. PubMed ID: 22724235
[No Abstract] [Full Text] [Related]
4. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
[TBL] [Abstract][Full Text] [Related]
5. Heart failure: recent advances in prevention and treatment.
Fonarow GC
Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
Kubota T; Takeshita A
Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
[TBL] [Abstract][Full Text] [Related]
8. Neurohormonal antagonism in heart failure: what is the optimal strategy?
Sackner-Bernstein JD; Hart D
Mt Sinai J Med; 2004 Mar; 71(2):115-26. PubMed ID: 15029403
[TBL] [Abstract][Full Text] [Related]
9. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
Vonder Muhll I; Liu P; Webb G
Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
[TBL] [Abstract][Full Text] [Related]
10. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist device.
Jiménez-Navarro M; Molero E; de Teresa E
N Engl J Med; 2002 Mar; 346(13):1023-5; author reply 1023-5. PubMed ID: 11924655
[No Abstract] [Full Text] [Related]
12. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
Novosel MK; Haghfelt TH
Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
Buckberg GD;
Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
[No Abstract] [Full Text] [Related]
14. Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes.
Barbour MM; Zuwallack A
Med Health R I; 2001 Feb; 84(2):55-8. PubMed ID: 11272661
[TBL] [Abstract][Full Text] [Related]
15. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
Mota T
Rev Port Cardiol; 2001 Mar; 20 Suppl 3():13-5. PubMed ID: 11409069
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
18. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
[TBL] [Abstract][Full Text] [Related]
19. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.
Masoudi FA; Havranek EP; Wolfe P; Gross CP; Rathore SS; Steiner JF; Ordin DL; Krumholz HM
Am Heart J; 2003 Aug; 146(2):250-7. PubMed ID: 12891192
[TBL] [Abstract][Full Text] [Related]
20. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
O'Connor CM; Arumugham P
Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
